2012

Consensus Outlook: Multiple Sclerosis

September 2012

From $4,995.00

Therapies for Solid Tumors

September 2012
Insight Pharma Reports

From $79.00

Alzheimer's Disease

July 2012
Insight Pharma Reports

From $299.00

The New Generation of Antibody Therapeutics

June 2012
Insight Pharma Reports

From $1,595.00

Pricing and Reimbursement in the US

January 2012

From $695.00

Report Topics